Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 33063 | 98 | 30.5 | 63% |
Classes in level above (level 2) |
| ID, lev. above |
Publications | Label for level above |
|---|---|---|
| 202 | 20434 | CLOPIDOGREL//PRASUGREL//ASPIRIN RESISTANCE |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | TRIFLUSAL | Author keyword | 34 | 61% | 37% | 36 |
| 2 | HTB | Author keyword | 2 | 43% | 3% | 3 |
| 3 | CAS 322 79 2 | Author keyword | 1 | 100% | 2% | 2 |
| 4 | PLATELET ANTIAGGREGANTS | Author keyword | 1 | 40% | 2% | 2 |
| 5 | BIOANAL PHARMACOKINET UNIT | Address | 1 | 50% | 1% | 1 |
| 6 | CIHR GRP VASC COGNIT IMPAIRMENT | Address | 1 | 50% | 1% | 1 |
| 7 | CLIN EXPT MEDMED | Address | 1 | 50% | 1% | 1 |
| 8 | DRUG DISCOVERY PK | Address | 1 | 50% | 1% | 1 |
| 9 | EXTRAPOLATION TO HUMANS | Author keyword | 1 | 50% | 1% | 1 |
| 10 | NEFROL HIPERTENS INVEST CARDIOVASC | Address | 1 | 50% | 1% | 1 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | TRIFLUSAL | 34 | 61% | 37% | 36 | Search TRIFLUSAL | Search TRIFLUSAL |
| 2 | HTB | 2 | 43% | 3% | 3 | Search HTB | Search HTB |
| 3 | CAS 322 79 2 | 1 | 100% | 2% | 2 | Search CAS+322+79+2 | Search CAS+322+79+2 |
| 4 | PLATELET ANTIAGGREGANTS | 1 | 40% | 2% | 2 | Search PLATELET+ANTIAGGREGANTS | Search PLATELET+ANTIAGGREGANTS |
| 5 | EXTRAPOLATION TO HUMANS | 1 | 50% | 1% | 1 | Search EXTRAPOLATION+TO+HUMANS | Search EXTRAPOLATION+TO+HUMANS |
| 6 | PRIMARY VASCULAR DYSREGULATION | 0 | 25% | 1% | 1 | Search PRIMARY+VASCULAR+DYSREGULATION | Search PRIMARY+VASCULAR+DYSREGULATION |
| 7 | REACTIVE MICROGLIA | 0 | 11% | 2% | 2 | Search REACTIVE+MICROGLIA | Search REACTIVE+MICROGLIA |
| 8 | ENTERIC COATED FORMULATION | 0 | 14% | 1% | 1 | Search ENTERIC+COATED+FORMULATION | Search ENTERIC+COATED+FORMULATION |
| 9 | PERIPROCEDURAL COMPLICATIONS | 0 | 14% | 1% | 1 | Search PERIPROCEDURAL+COMPLICATIONS | Search PERIPROCEDURAL+COMPLICATIONS |
| 10 | ISCHEMIA BRAIN | 0 | 13% | 1% | 1 | Search ISCHEMIA++BRAIN | Search ISCHEMIA++BRAIN |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | 2 HYDROXY 4 TRIFLUOROMETHYLBENZOIC ACID | 8 | 52% | 11% | 11 |
| 2 | 4 TRIFLUOROMETHYL DERIVATIVES | 6 | 50% | 9% | 9 |
| 3 | MAIN METABOLITE HTB | 6 | 100% | 4% | 4 |
| 4 | TRIFLUSAL | 2 | 27% | 7% | 7 |
| 5 | HTB | 1 | 100% | 2% | 2 |
| 6 | CYCLOOXYGENASES 1 AND 2 | 1 | 50% | 1% | 1 |
| 7 | YOUNG BRAIN | 1 | 50% | 1% | 1 |
| 8 | MICROTHROMBI FORMATION | 0 | 33% | 1% | 1 |
| 9 | MULTICELLULAR PROCESSES | 0 | 33% | 1% | 1 |
| 10 | RENAL FUNCTION TESTS | 0 | 33% | 1% | 1 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references |
% act. ref. to same field |
|---|---|---|---|---|
| Triflusal: An Old Drug in Modern Antiplatelet Therapy. Review of Its Action, Use, Safety and Effectiveness | 2009 | 11 | 48 | 46% |
| A Phase I study to characterize the multiple-dose pharmacokinetics, pharmacodynamics and safety of new enteric-coated triflusal formulations in healthy male volunteers | 2011 | 1 | 18 | 67% |
| Triflusal - A review of its use in cerebral infarction and myocardial infarction, and as thromboprophylaxis in atrial fibrillation | 2006 | 22 | 51 | 57% |
| Triflusal: An antiplatelet drug with a neuroprotective effect? | 2006 | 8 | 39 | 54% |
| Triflusal for preventing serious vascular events in people at high risk | 2005 | 1 | 26 | 50% |
| THE RELEVANCE OF CLINICAL PATHOLOGY TO TOXICOLOGY STUDIES | 1993 | 5 | 9 | 22% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | BIOANAL PHARMACOKINET UNIT | 1 | 50% | 1.0% | 1 |
| 2 | CIHR GRP VASC COGNIT IMPAIRMENT | 1 | 50% | 1.0% | 1 |
| 3 | CLIN EXPT MEDMED | 1 | 50% | 1.0% | 1 |
| 4 | DRUG DISCOVERY PK | 1 | 50% | 1.0% | 1 |
| 5 | NEFROL HIPERTENS INVEST CARDIOVASC | 1 | 50% | 1.0% | 1 |
| 6 | PIFRECV | 1 | 50% | 1.0% | 1 |
| 7 | SECC VASC | 1 | 50% | 1.0% | 1 |
| 8 | SEVERANCE CHECK UP | 1 | 50% | 1.0% | 1 |
| 9 | CLIN DEV MED ADVICE | 0 | 25% | 1.0% | 1 |
| 10 | POLIGON IND RIERA CALDES | 0 | 25% | 1.0% | 1 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000182216 | DIFERENTIATION//HUMAN PANCREATIC CARCINOMA CELL LINES//LIVER SPECIFIC ANTIGEN |
| 2 | 0.0000157505 | INDOBUFEN//INDOBUFEN ENANTIOMERS//ATHEROSCLEROSIS PERIPHERAL |
| 3 | 0.0000157486 | SPONTANEOUS PLATELET AGGREGATION//PARTICLE COUNTING METHOD//AGGREGOMETER |
| 4 | 0.0000153618 | 9 ALLYLPURINES//ANTIPLATELET COMPOUNDS//HAMILTON GEN HOSP CLIN UNIT |
| 5 | 0.0000143993 | TRANSIENT ISCHEMIC ATTACK//ABCD2 SCORE//TIA |
| 6 | 0.0000131195 | ALLIED HEALTH SERVICES//ENHANCED PRIMARY CARE//RURAL CLIN NO NSW |
| 7 | 0.0000122166 | SECT ZOOL CYTOL//KEYMOLNET//RELA ACETYLATION |
| 8 | 0.0000091238 | ABNORMAL BLOOD LIPIDS//BEYIN CERRAHI SERV//BRAIN INJURY GRP BIOMED |
| 9 | 0.0000077329 | TRAPIDIL//CAS 15421 84 8//SEKT KLIN PHARMAKOL |
| 10 | 0.0000077238 | ASPIRIN RESISTANCE//PFA 100//THROMBOSTAT |